Sean Wuxiong Cao Exercises Options at NovaBridge Biosciences (NBP) — SEC Form 4, Sep 08, 2026

SEC Form 4 · No Market Transaction
Option Exercise

Derivative exercise — no open market transaction.

Reporting Owner
TXN 2026-09-03 · FILED 2026-09-08
Equity Position 374K sh 35,073 → 374,445
Equity Change +967.6% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-09-08
Report Date
2026-09-08
Accession No.
0002109966-26-000006
Accepted At
2026-09-08 21:51 UTC
Reporting Owner
Name Relationship
Sean Wuxiong Cao CIK 0002109966
Officer
Sean Wuxiong Cao at NovaBridge Biosciences Full insider history
Bought (12 mo) —
Sold (12 mo) $122,488
More from this insider at NovaBridge Biosciences
2026-09-11 Sell -$79,904 View
2026-06-24 Award — View
2026-05-18 Sell -$42,584 View
All filings by this insider at NovaBridge Biosciences
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Ordinary SharesF1F2F3 2026-09-03 M - Exercise 235,136 A — 270,209 Direct
Ordinary SharesF1F4F3 2026-09-03 M - Exercise 104,236 A — 374,445 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Restricted Share UnitsF3F5F5F1 2026-09-03 M - Exercise 102,233 D $0.00 102,233 Ordinary Shares Direct
Restricted Share UnitsF3F6F6F1 2026-09-03 M - Exercise 45,320 D $0.00 45,320 Ordinary Shares Direct
Footnotes (6)
F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Show more
F2
Reported securities are represented by 102,233 ADSs Show more
F3
Each restricted stock unit ("RSU") represents a contingent right to receive one ADS. Show more
F4
Reported securities are represented by 45,320 ADSs. Show more
F5
On September 3, 2025, the Reporting Person was granted 408,933 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month. Show more
F6
On June 22, 2026, the Reporting Person was granted 181,280 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on September 3, 2026 and the balance vesting ratably over the subsequent 12 quarters on the third day of each third month. Show more
5%+ Holders · 13D/G 3 filers
Other insiders at NovaBridge Biosciences
All NovaBridge Biosciences insider activity
GET /v1/forms/4/0002109966-26-000006 API docs
View Original SEC Filing